<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="The training dataset contains real-life survival data from patients who underwent primary surgery for breast cancer between 1978 and 1993 in Rotterdam. The patients were followed until 2007, resulting in a model development cohort of 2982 patients after exclusions. The primary outcome measured was recurrence-free survival, defined as the time from primary surgery to recurrence or death.
The validation dataset consists of 686 patients with primary node-positive breast cancer from the German Breast Cancer Study Group. In this cohort, 285 patients suffered a recurrence or died within 5 years of follow-up, while 280 were censored before 5 years. Five-year predictions were chosen as that was the lowest median survival from the two cohorts (Rotterdam cohort, 6.7 years; German cohort, 4.9 years)."><title>Breast Cancer Survival Data from Rotterdam and Germany — simulatedsurvivaldata • CalibrationCurves</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.11/clipboard.min.js" integrity="sha512-7O5pXpc0oCRrxk8RUfDYFgn0nO1t+jLuIOQdOMRp4APB7uZ4vSjspzp5y6YDtDs4VzUSTbWzBFZ/LKJhnyFOKw==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Breast Cancer Survival Data from Rotterdam and Germany — simulatedsurvivaldata"><meta property="og:description" content="The training dataset contains real-life survival data from patients who underwent primary surgery for breast cancer between 1978 and 1993 in Rotterdam. The patients were followed until 2007, resulting in a model development cohort of 2982 patients after exclusions. The primary outcome measured was recurrence-free survival, defined as the time from primary surgery to recurrence or death.
The validation dataset consists of 686 patients with primary node-positive breast cancer from the German Breast Cancer Study Group. In this cohort, 285 patients suffered a recurrence or died within 5 years of follow-up, while 280 were censored before 5 years. Five-year predictions were chosen as that was the lowest median survival from the two cohorts (Rotterdam cohort, 6.7 years; German cohort, 4.9 years)."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light" data-bs-theme="light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">CalibrationCurves</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">2.0.7</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="nav-item">
  <a class="nav-link" href="../articles/CalibrationCurves.html">Get started</a>
</li>
<li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"></ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Breast Cancer Survival Data from Rotterdam and Germany</h1>
      
      <div class="d-none name"><code>survivaltraindata.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The training dataset contains real-life survival data from patients who underwent primary surgery for breast cancer between 1978 and 1993 in Rotterdam. The patients were followed until 2007, resulting in a model development cohort of 2982 patients after exclusions. The primary outcome measured was recurrence-free survival, defined as the time from primary surgery to recurrence or death.</p>
<p>The validation dataset consists of 686 patients with primary node-positive breast cancer from the German Breast Cancer Study Group. In this cohort, 285 patients suffered a recurrence or died within 5 years of follow-up, while 280 were censored before 5 years. Five-year predictions were chosen as that was the lowest median survival from the two cohorts (Rotterdam cohort, 6.7 years; German cohort, 4.9 years).</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="va">trainDataSurvival</span><span class="op">)</span></span>
<span>  <span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="va">testDataSurvival</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="format">Format<a class="anchor" aria-label="anchor" href="#format"></a></h2>
    <p>A data frame with observations on the following 26 variables.</p><dl><dt>pid</dt>
<dd><p>patient identifier</p></dd>

    <dt>year</dt>
<dd><p>year of surgery</p></dd>

    <dt>age</dt>
<dd><p>age at surgery</p></dd>

    <dt>meno</dt>
<dd><p>menopausal status (0 = premenopausal, 1 = postmenopausal)</p></dd>

    <dt>size</dt>
<dd><p>tumor size, a factor with levels &lt;= 20, 20-50, &gt;50</p></dd>

    <dt>grade</dt>
<dd><p>differentiation grade</p></dd>

    <dt>nodes</dt>
<dd><p>number of positive lymph nodes</p></dd>

    <dt>pgr</dt>
<dd><p>progesterone receptors (fmol/l)</p></dd>

    <dt>er</dt>
<dd><p>estrogen receptors (fmol/l)</p></dd>

    <dt>hormon</dt>
<dd><p>hormonal treatment (0 = no, 1 = yes)</p></dd>

    <dt>chemo</dt>
<dd><p>chemotherapy</p></dd>

    <dt>rtime</dt>
<dd><p>days to relapse or last follow-up</p></dd>

    <dt>recur</dt>
<dd><p>0 = no relapse, 1 = relapse</p></dd>

    <dt>dtime</dt>
<dd><p>days to death or last follow-up</p></dd>

    <dt>death</dt>
<dd><p>0 = alive, 1 = dead</p></dd>

    <dt>ryear</dt>
<dd><p>Follow-up time for RFS, in years (numeric)</p></dd>

    <dt>rfs</dt>
<dd><p>Recurrence-free survival status (0 = no event, 1 = event) (numeric)</p></dd>

    <dt>pgr2</dt>
<dd><p>Winsorized progesterone receptor level (numeric)</p></dd>

    <dt>nodes2</dt>
<dd><p>Winsorized node count (numeric)</p></dd>

    <dt>csize</dt>
<dd><p>Categorized tumor size, copied from <code>size</code> (factor)</p></dd>

    <dt>cnode</dt>
<dd><p>Categorized node involvement (factor: "0", "1-3", "&gt;3")</p></dd>
<dt>grade3</dt>
<dd><p>Recoded grade factor (levels: "1-2", "3")</p></dd>
<dt>nodes3</dt>
<dd><p>Restricted cubic spline basis for <code>nodes2</code> (numeric)</p></dd>

    <dt>pgr3</dt>
<dd><p>Restricted cubic spline basis for original <code>pgr</code> (numeric)</p></dd>

    <dt>epoch</dt>
<dd><p>Follow-up epoch indicator after splitting at 5 years (numeric)</p></dd>

    
</dl></div>
    <div class="section level2">
    <h2 id="details">Details<a class="anchor" aria-label="anchor" href="#details"></a></h2>
    <p>The data sets are based on the publicly available code and data used in the repository
<a href="https://github.com/danielegiardiello/Prediction_performance_survival" class="external-link">Prediction_performance_survival</a>
by Giardiello et al. (2023), which accompanies the Annals of Internal Medicine article
"Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models".</p>
<p>All preprocessing steps, such as converting survival time to years, defining recurrence-free survival status via
`rfs = pmax(recur, death)`, correcting 43 discordant cases using death time, 99th-percentile winsorization of `pgr` and `nodes`,
spline transformations (`nodes3`, `pgr3`), splitting follow-up at 5 years (`epoch`), and recoding categorical variables
(`csize`, `cnode`, `grade3`)—were performed exactly as in the Giardiello code.</p>
<p>The training dataset, <code>trainDataSurvival</code>, consists of 2982 patients, with 1713 events occurring over a maximum
follow-up time of 19.3 years. The estimated median potential follow-up time, calculated using the reverse Kaplan-
method, was 9.3 years. Out of these patients, 1275 suffered a recurrence or death within the follow-up time of interest
(5 years), and 126 were censored before 5 years.</p>
<p>The validation dataset, <code>testDataSurvival</code>, consists of 686 patients with primary node-positive breast cancer
from the German Breast Cancer Study Group. In this cohort, 285 patients suffered a recurrence or died within 5 years
of follow-up, while 280 were censored before 5 years. Five-year predictions were chosen as that was the lowest median
survival from the two cohorts (Rotterdam cohort, 6.7 years; German cohort, 4.9 years).</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>David J. McLernon, Daniele Giardiello, Ben Van Calster, et al. (2023). Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models. <em>Annals of Internal Medicine</em>, 176(1), pp. 105-114, doi:10.7326/M22-0844</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="va">testDataSurvival</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="co">## Explore the structure of the dataset</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/utils/str.html" class="external-link">str</a></span><span class="op">(</span><span class="va">testDataSurvival</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 'data.frame':	686 obs. of  21 variables:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ pid    : int  132 1575 1140 769 130 1642 475 973 569 1180 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ age    : int  49 55 56 45 65 48 48 37 67 45 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ meno   : int  0 1 1 0 1 0 0 0 1 0 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ size   : int  18 20 40 25 30 52 21 20 20 30 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ grade  : int  2 3 3 3 2 2 3 2 2 2 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ nodes  : int  2 16 3 1 5 11 8 9 1 1 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ pgr    : int  0 0 0 0 0 0 0 0 0 0 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ er     : int  0 0 0 4 36 0 0 0 0 0 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ hormon : int  0 0 0 0 1 0 0 1 1 0 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ rfstime: int  1838 403 1603 177 1855 842 293 42 564 1093 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ status : int  0 1 0 0 0 1 1 0 1 1 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ cnode  : Factor w/ 3 levels "0","1-3","&gt;3": 2 3 2 2 3 3 3 3 2 2 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ csize  : Factor w/ 3 levels "&lt;=20","20-50",..: 1 1 2 2 2 3 2 1 1 2 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ pgr2   : num  0 0 0 0 0 0 0 0 0 0 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ nodes2 : num  2 16 3 1 5 11 8 9 1 1 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ grade3 : Factor w/ 2 levels "1-2","3": 1 2 2 2 1 1 2 1 1 1 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ nodes3 : num  0.0849 4.2222 0.2222 0.0123 0.6543 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ pgr3   : num  0 0 0 0 0 0 0 0 0 0 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ ryear  : num  5 1.103 4.389 0.485 5 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ rfs    : num  0 1 0 0 0 1 1 0 1 1 ...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  $ epoch  : num  1 1 1 1 1 1 1 1 1 1 ...</span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Bavo De Cock Campo.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.9.</p>
</div>

    </footer></div>

  

  

  </body></html>

